Coronary artery calcification on non-gated CT thorax tied to risk of cardiovascular disease, death: Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-02-10 05:30 GMT   |   Update On 2023-02-10 07:40 GMT
Advertisement

UK: A recent study has shown that the severity and presence of coronary artery calcification (CAC) assessed on NC-NECG-CTT (non-contrast non-ECG-gated CT thorax) corresponds to short-term cardiovascular events and death. The study was featured in European Radiology on 27 January 2023.

The study found that patients aged 40-70 years without known cardiovascular disease but with CAC on NC-NECG-CTT were at higher risk of cardiovascular disease events than those without CAC. CAC (Agatston) score above 100 in these patients confers a 5.7-fold increase in short-term CVD events risk.

Advertisement

Coronary artery calcification is a marker of coronary atherosclerosis, strongly linked with major CVD events in asymptomatic people. CACS (CAC scoring) is the best-established imaging test for CVD risk stratification. Non-gated CT scans allow for either quantitative or semiquantitative CACS, with a high correlation to gated CT studies. Still, there have been concerns regarding the cost-effectiveness and availability of systematic screening with ECG-gated CAC scanning.

Against the above background, Maria T. A. Wetscherek, from Cambridge University Hospitals NHS Foundation Trust in Cambridge, UK, and colleagues aimed to assess CAC on non-contrast non-ECG-gated CT thorax. Also, they evaluated its correlation with short-term risk of cardiovascular disease events and death.

For this purpose, the researchers conducted a single-institution retrospective study that included participants who underwent NC-NECG-CTT over six months. Those with known CVD were excluded. CAC presence was quantified and assessed by CACS (Agatston score). CAA severity was defined as severe (> 400), moderate (100–400), or mild (< 100).

CVD events, including myocardial infarction, CVD death, ischemic stroke, acute peripheral atherosclerotic ischaemia, revascularisation procedures, and all-cause mortality, were recorded over a median of 3.5 years. The team performed Cox proportional-hazards regression modelling, including age, gender, CACS, and CVD risk factors (diabetes mellitus, hypertension, smoking, family history of CVD, dyslipidemia).

The researchers reported the following findings:

  • Of the total 717 eligible cases, 45% had CAC.
  • There was only one CVD event in patients without CAC, compared to 26 CVD events, including five deaths in CAC patients.
  • The severity and presence of CAC correlated with CVD events.
  • A CACS > 100 was significantly associated with CVD events, a hazard ratio (HR) of 5.74, and all-cause mortality, HR 1.7.
  • Ever-smokers with CAC had a remarkably higher risk for all-cause mortality than never-smokers. Still, smoking status was not an independent predictor for CVD events in any subgroup category of CAC severity.

"Our findings confirmed that CAC on routine clinically-indicated CT thorax can be used for the identification of those at greater risk of future CVD events," the researchers wrote.

"Our study, which is the first to investigate the prognostic value of CACS cut-off 100 for CV events and death, supports the current guidelines recommending reporting of CAC on all thoracic CTs to ease adequate risk modification and preventive treatment," they conclude.

Reference:

Wetscherek, M.T.A., McNaughton, E., Majcher, V. et al. Incidental coronary artery calcification on non-gated CT thorax correlates with risk of cardiovascular events and death. Eur Radiol (2023). https://doi.org/10.1007/s00330-023-09428-z

Tags:    
Article Source : European Radiology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News